BRILLIANCE trial
Credit: OHSU News
Carlene Knight undergoes an eye exam by Mark Pennesi, M.D., Ph.D., at Oregon Health & Science Universitys Casey Eye Institute on April 29, 2021. As a participant in the BRILLIANCE clinical trial, Knight received an experimental gene-editing treatment that aims to improve eye sight. (OHSU/Josh Andersen)